ICH Impurity Thresholds are Unrealistic for Antibiotics
This article was originally published in The Gold Sheet
EMA's proposal to apply the same ICH impurity limits to antibiotics produced by fermentation and semi-synthetic methods as new drug substances is considered unrealistic, and could result in market withdrawals of these products.
You may also be interested in...
Rather than blame employees for ignoring 397 product complaints, Teligent should have fixed complaint handling system, US FDA warning letter says.
US FDA officials tell industry that implementing a quality metrics program is an agency priority and that a rejiggered program will incorporate various elements of other quality metrics initiatives being piloted by the agency, industry and academia.
Data integrity issues were raised in many warning letters to active pharmaceutical ingredient manufacturers over the past four years.